Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03195998 · ClinicalTrials.gov registry record
Validity of Transcutaneous Bilirubin Monitoring in Preterm Infants
A clinical trial, sponsored by Pediatrix.
- Completed
- Registry status
- 166
- Enrollment target
NCT03195998 is a clinical trial that has completed, run by Pediatrix. The registered enrollment target is 166 participants.
The verdict
NCT03195998 has completed, sponsored by Pediatrix.
- COMPLETED
- Registry status
- 166 participants
- Enrollment target
Study Summary
The most common and widely accepted method of monitoring bilirubin levels in neonates is the use of the laboratory analyzation of serum blood levels. Unfortunately this method is invasive, painful, and can progressively lead to increased blood loss in the neonate. It also requires the use of additional time and resources to coordinate sending the sample to the laboratory and processing the specimen in the lab. There exists a different option for obtaining bilirubin levels in neonates which is the transcutaneous bilirubinometer. This device detects bilirubin levels at the bedside and has been validated for use in infants born at \> 35 weeks gestation. There are a limited number of studies evaluating its use in premature infants. Our aim is to assess the diagnostic accuracy and efficacy of transcutaneous bilirubinometry (TcB) of the Dräger JM-103 by comparing (TcB) readings to total serum bilirubin (TSB) results in neonates born at 23 0/7-34 6/7 weeks gestation.
Interventions
- DIAGNOSTIC_TEST TcB Measurement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2017-06-30 |
| Est. Completion | 2019-02-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03195998
The ClinicalTrials.gov registry entry for NCT03195998 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 166 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pediatrix, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TcB Measurement is the first listed.
NCT03195998 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03195998 about?
NCT03195998 is a clinical study titled "Validity of Transcutaneous Bilirubin Monitoring in Preterm Infants". The most common and widely accepted method of monitoring bilirubin levels in neonates is the use of the laboratory analyzation of serum blood levels. Unfortunately this method is invasive, painful, and can progressively lead to increased blood loss in the neonate. It also requires the use of additio...
What is the current status of trial NCT03195998?
This trial is currently completed. The enrollment target is 166 participants. The study started on 2017-06-30. Estimated completion is 2019-02-01.
What interventions are being tested in trial NCT03195998?
The interventions under investigation include: TcB Measurement (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03195998?
This trial is sponsored by Pediatrix, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.